Risk aversion and COVID-19 vaccine hesitancy

Anthony Lepinteur*, Liyousew G. Borga, Andrew E. Clark, Claus Vögele, Conchita D’Ambrosio

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)


We here investigate the role of risk aversion in COVID-19 vaccine hesitancy. The theoretical effect is ambiguous, as both COVID-19 infection and vaccination side-effects involve probabilistic elements. In large-scale data covering five European countries, we find that vaccine hesitancy falls with risk aversion, so that COVID-19 infection is perceived as involving greater risk than is vaccination.

Original languageEnglish
Pages (from-to)1659-1669
Number of pages11
JournalHealth Economics (United Kingdom)
Issue number8
Early online date5 May 2023
Publication statusPublished - Aug 2023


  • COME-HERE survey
  • Europe
  • risk aversion
  • vaccine hesitancy


Dive into the research topics of 'Risk aversion and COVID-19 vaccine hesitancy'. Together they form a unique fingerprint.

Cite this